NCT04144439 Effect of GABA on ADHD and Seizures in Children With Epilepsy.
| NCT ID | NCT04144439 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Sherief Abd-Elsalam |
| Condition | Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2018-07-01 |
| Primary Completion | 2028-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 30 participants in total. It began in 2018-07-01 with a primary completion date of 2028-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Effect of GABA on ADHD and seizures in Children with epilepsy.
Eligibility Criteria
Inclusion Criteria: * Epilepsy * ADHD Exclusion Criteria: * Epilepsy without ADHD
Contact & Investigator
Abeer Salamah, Lecturer
PRINCIPAL INVESTIGATOR
Lecturer of Pediatrics - Kafr Elsheikh University
Frequently Asked Questions
Who can join the NCT04144439 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 18 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT04144439 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT04144439 currently recruiting?
Yes, NCT04144439 is actively recruiting participants. Contact the research team at sheriefabdelsalam@yahoo.com for enrollment information.
Where is the NCT04144439 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT04144439 clinical trial?
NCT04144439 is sponsored by Sherief Abd-Elsalam. The principal investigator is Abeer Salamah, Lecturer at Lecturer of Pediatrics - Kafr Elsheikh University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.